The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cefuroxime Sodium for Injection Market Research Report 2024

Global Cefuroxime Sodium for Injection Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1762020

No of Pages : 115

Synopsis
Global Cefuroxime Sodium for Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cefuroxime Sodium for Injection market research.
Key manufacturers engaged in the Cefuroxime Sodium for Injection industry include Hunan Kelun Pharmaceutical Co., Ltd., GSK, Qilu Antibiotics Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Guangzhou Baiyunshan Pharmaceutical Co.,Ltd.., Zhe Jiang Jutai Pharmaceutical Co., Ltd, Nanchang Lijian Pharmaceutical Co., Ltd., Zhejiang Huidisen Pharmaceutical Co., Ltd. and Fujian Fukang Pharmaceutical Co., Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Cefuroxime Sodium for Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cefuroxime Sodium for Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cefuroxime Sodium for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Hunan Kelun Pharmaceutical Co., Ltd.
GSK
Qilu Antibiotics Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Guangzhou Baiyunshan Pharmaceutical Co.,Ltd..
Zhe Jiang Jutai Pharmaceutical Co., Ltd
Nanchang Lijian Pharmaceutical Co., Ltd.
Zhejiang Huidisen Pharmaceutical Co., Ltd.
Fujian Fukang Pharmaceutical Co., Ltd.
Hangzhou Senze Pharmaceutical Technology Co., Ltd.
Livzon Pharmaceutical Group Inc.
ShenZhen Lijian Pharmaceutical Co., Ltd.
Lionco Pharmaceutical Group Co.,Ltd.
Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Co., Ltd.
Pace Biotech
Biobrick Pharma
Asterisk Laboratories
Hikma Pharmaceuticals
Sun Pharma
Teligent
Segment by Type
0.5g
0.75g
1g
1.5g
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Cefuroxime Sodium for Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Cefuroxime Sodium for Injection Market Overview
1.1 Product Overview and Scope of Cefuroxime Sodium for Injection
1.2 Cefuroxime Sodium for Injection Segment by Type
1.2.1 Global Cefuroxime Sodium for Injection Market Value Comparison by Type (2023-2029)
1.2.2 0.5g
1.2.3 0.75g
1.2.4 1g
1.2.5 1.5g
1.3 Cefuroxime Sodium for Injection Segment by Application
1.3.1 Global Cefuroxime Sodium for Injection Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Cefuroxime Sodium for Injection Market Size Estimates and Forecasts
1.4.1 Global Cefuroxime Sodium for Injection Revenue 2018-2029
1.4.2 Global Cefuroxime Sodium for Injection Sales 2018-2029
1.4.3 Global Cefuroxime Sodium for Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Cefuroxime Sodium for Injection Market Competition by Manufacturers
2.1 Global Cefuroxime Sodium for Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Cefuroxime Sodium for Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Cefuroxime Sodium for Injection Average Price by Manufacturers (2018-2023)
2.4 Global Cefuroxime Sodium for Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Cefuroxime Sodium for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cefuroxime Sodium for Injection, Product Type & Application
2.7 Cefuroxime Sodium for Injection Market Competitive Situation and Trends
2.7.1 Cefuroxime Sodium for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cefuroxime Sodium for Injection Players Market Share by Revenue
2.7.3 Global Cefuroxime Sodium for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cefuroxime Sodium for Injection Retrospective Market Scenario by Region
3.1 Global Cefuroxime Sodium for Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Cefuroxime Sodium for Injection Global Cefuroxime Sodium for Injection Sales by Region: 2018-2029
3.2.1 Global Cefuroxime Sodium for Injection Sales by Region: 2018-2023
3.2.2 Global Cefuroxime Sodium for Injection Sales by Region: 2024-2029
3.3 Global Cefuroxime Sodium for Injection Global Cefuroxime Sodium for Injection Revenue by Region: 2018-2029
3.3.1 Global Cefuroxime Sodium for Injection Revenue by Region: 2018-2023
3.3.2 Global Cefuroxime Sodium for Injection Revenue by Region: 2024-2029
3.4 North America Cefuroxime Sodium for Injection Market Facts & Figures by Country
3.4.1 North America Cefuroxime Sodium for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Cefuroxime Sodium for Injection Sales by Country (2018-2029)
3.4.3 North America Cefuroxime Sodium for Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cefuroxime Sodium for Injection Market Facts & Figures by Country
3.5.1 Europe Cefuroxime Sodium for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Cefuroxime Sodium for Injection Sales by Country (2018-2029)
3.5.3 Europe Cefuroxime Sodium for Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cefuroxime Sodium for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Cefuroxime Sodium for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Cefuroxime Sodium for Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Cefuroxime Sodium for Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cefuroxime Sodium for Injection Market Facts & Figures by Country
3.7.1 Latin America Cefuroxime Sodium for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Cefuroxime Sodium for Injection Sales by Country (2018-2029)
3.7.3 Latin America Cefuroxime Sodium for Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Cefuroxime Sodium for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Cefuroxime Sodium for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Cefuroxime Sodium for Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Cefuroxime Sodium for Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cefuroxime Sodium for Injection Sales by Type (2018-2029)
4.1.1 Global Cefuroxime Sodium for Injection Sales by Type (2018-2023)
4.1.2 Global Cefuroxime Sodium for Injection Sales by Type (2024-2029)
4.1.3 Global Cefuroxime Sodium for Injection Sales Market Share by Type (2018-2029)
4.2 Global Cefuroxime Sodium for Injection Revenue by Type (2018-2029)
4.2.1 Global Cefuroxime Sodium for Injection Revenue by Type (2018-2023)
4.2.2 Global Cefuroxime Sodium for Injection Revenue by Type (2024-2029)
4.2.3 Global Cefuroxime Sodium for Injection Revenue Market Share by Type (2018-2029)
4.3 Global Cefuroxime Sodium for Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Cefuroxime Sodium for Injection Sales by Application (2018-2029)
5.1.1 Global Cefuroxime Sodium for Injection Sales by Application (2018-2023)
5.1.2 Global Cefuroxime Sodium for Injection Sales by Application (2024-2029)
5.1.3 Global Cefuroxime Sodium for Injection Sales Market Share by Application (2018-2029)
5.2 Global Cefuroxime Sodium for Injection Revenue by Application (2018-2029)
5.2.1 Global Cefuroxime Sodium for Injection Revenue by Application (2018-2023)
5.2.2 Global Cefuroxime Sodium for Injection Revenue by Application (2024-2029)
5.2.3 Global Cefuroxime Sodium for Injection Revenue Market Share by Application (2018-2029)
5.3 Global Cefuroxime Sodium for Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Hunan Kelun Pharmaceutical Co., Ltd.
6.1.1 Hunan Kelun Pharmaceutical Co., Ltd. Corporation Information
6.1.2 Hunan Kelun Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Hunan Kelun Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Hunan Kelun Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Product Portfolio
6.1.5 Hunan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GSK Cefuroxime Sodium for Injection Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Qilu Antibiotics Pharmaceutical Co., Ltd.
6.3.1 Qilu Antibiotics Pharmaceutical Co., Ltd. Corporation Information
6.3.2 Qilu Antibiotics Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Qilu Antibiotics Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Qilu Antibiotics Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Product Portfolio
6.3.5 Qilu Antibiotics Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Southwest Pharmaceutical Co., Ltd.
6.4.1 Southwest Pharmaceutical Co., Ltd. Corporation Information
6.4.2 Southwest Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Southwest Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Southwest Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Product Portfolio
6.4.5 Southwest Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Guangzhou Baiyunshan Pharmaceutical Co.,Ltd..
6.5.1 Guangzhou Baiyunshan Pharmaceutical Co.,Ltd.. Corporation Information
6.5.2 Guangzhou Baiyunshan Pharmaceutical Co.,Ltd.. Description and Business Overview
6.5.3 Guangzhou Baiyunshan Pharmaceutical Co.,Ltd.. Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Guangzhou Baiyunshan Pharmaceutical Co.,Ltd.. Cefuroxime Sodium for Injection Product Portfolio
6.5.5 Guangzhou Baiyunshan Pharmaceutical Co.,Ltd.. Recent Developments/Updates
6.6 Zhe Jiang Jutai Pharmaceutical Co., Ltd
6.6.1 Zhe Jiang Jutai Pharmaceutical Co., Ltd Corporation Information
6.6.2 Zhe Jiang Jutai Pharmaceutical Co., Ltd Description and Business Overview
6.6.3 Zhe Jiang Jutai Pharmaceutical Co., Ltd Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Zhe Jiang Jutai Pharmaceutical Co., Ltd Cefuroxime Sodium for Injection Product Portfolio
6.6.5 Zhe Jiang Jutai Pharmaceutical Co., Ltd Recent Developments/Updates
6.7 Nanchang Lijian Pharmaceutical Co., Ltd.
6.6.1 Nanchang Lijian Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Nanchang Lijian Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Nanchang Lijian Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nanchang Lijian Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Product Portfolio
6.7.5 Nanchang Lijian Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Zhejiang Huidisen Pharmaceutical Co., Ltd.
6.8.1 Zhejiang Huidisen Pharmaceutical Co., Ltd. Corporation Information
6.8.2 Zhejiang Huidisen Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Zhejiang Huidisen Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Zhejiang Huidisen Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Product Portfolio
6.8.5 Zhejiang Huidisen Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Fujian Fukang Pharmaceutical Co., Ltd.
6.9.1 Fujian Fukang Pharmaceutical Co., Ltd. Corporation Information
6.9.2 Fujian Fukang Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Fujian Fukang Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Fujian Fukang Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Product Portfolio
6.9.5 Fujian Fukang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Hangzhou Senze Pharmaceutical Technology Co., Ltd.
6.10.1 Hangzhou Senze Pharmaceutical Technology Co., Ltd. Corporation Information
6.10.2 Hangzhou Senze Pharmaceutical Technology Co., Ltd. Description and Business Overview
6.10.3 Hangzhou Senze Pharmaceutical Technology Co., Ltd. Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Hangzhou Senze Pharmaceutical Technology Co., Ltd. Cefuroxime Sodium for Injection Product Portfolio
6.10.5 Hangzhou Senze Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
6.11 Livzon Pharmaceutical Group Inc.
6.11.1 Livzon Pharmaceutical Group Inc. Corporation Information
6.11.2 Livzon Pharmaceutical Group Inc. Cefuroxime Sodium for Injection Description and Business Overview
6.11.3 Livzon Pharmaceutical Group Inc. Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Livzon Pharmaceutical Group Inc. Cefuroxime Sodium for Injection Product Portfolio
6.11.5 Livzon Pharmaceutical Group Inc. Recent Developments/Updates
6.12 ShenZhen Lijian Pharmaceutical Co., Ltd.
6.12.1 ShenZhen Lijian Pharmaceutical Co., Ltd. Corporation Information
6.12.2 ShenZhen Lijian Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Description and Business Overview
6.12.3 ShenZhen Lijian Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 ShenZhen Lijian Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Product Portfolio
6.12.5 ShenZhen Lijian Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Lionco Pharmaceutical Group Co.,Ltd.
6.13.1 Lionco Pharmaceutical Group Co.,Ltd. Corporation Information
6.13.2 Lionco Pharmaceutical Group Co.,Ltd. Cefuroxime Sodium for Injection Description and Business Overview
6.13.3 Lionco Pharmaceutical Group Co.,Ltd. Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Lionco Pharmaceutical Group Co.,Ltd. Cefuroxime Sodium for Injection Product Portfolio
6.13.5 Lionco Pharmaceutical Group Co.,Ltd. Recent Developments/Updates
6.14 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Co., Ltd.
6.14.1 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Co., Ltd. Corporation Information
6.14.2 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Description and Business Overview
6.14.3 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Co., Ltd. Cefuroxime Sodium for Injection Product Portfolio
6.14.5 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Pace Biotech
6.15.1 Pace Biotech Corporation Information
6.15.2 Pace Biotech Cefuroxime Sodium for Injection Description and Business Overview
6.15.3 Pace Biotech Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Pace Biotech Cefuroxime Sodium for Injection Product Portfolio
6.15.5 Pace Biotech Recent Developments/Updates
6.16 Biobrick Pharma
6.16.1 Biobrick Pharma Corporation Information
6.16.2 Biobrick Pharma Cefuroxime Sodium for Injection Description and Business Overview
6.16.3 Biobrick Pharma Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Biobrick Pharma Cefuroxime Sodium for Injection Product Portfolio
6.16.5 Biobrick Pharma Recent Developments/Updates
6.17 Asterisk Laboratories
6.17.1 Asterisk Laboratories Corporation Information
6.17.2 Asterisk Laboratories Cefuroxime Sodium for Injection Description and Business Overview
6.17.3 Asterisk Laboratories Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Asterisk Laboratories Cefuroxime Sodium for Injection Product Portfolio
6.17.5 Asterisk Laboratories Recent Developments/Updates
6.18 Hikma Pharmaceuticals
6.18.1 Hikma Pharmaceuticals Corporation Information
6.18.2 Hikma Pharmaceuticals Cefuroxime Sodium for Injection Description and Business Overview
6.18.3 Hikma Pharmaceuticals Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Hikma Pharmaceuticals Cefuroxime Sodium for Injection Product Portfolio
6.18.5 Hikma Pharmaceuticals Recent Developments/Updates
6.19 Sun Pharma
6.19.1 Sun Pharma Corporation Information
6.19.2 Sun Pharma Cefuroxime Sodium for Injection Description and Business Overview
6.19.3 Sun Pharma Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Sun Pharma Cefuroxime Sodium for Injection Product Portfolio
6.19.5 Sun Pharma Recent Developments/Updates
6.20 Teligent
6.20.1 Teligent Corporation Information
6.20.2 Teligent Cefuroxime Sodium for Injection Description and Business Overview
6.20.3 Teligent Cefuroxime Sodium for Injection Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Teligent Cefuroxime Sodium for Injection Product Portfolio
6.20.5 Teligent Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cefuroxime Sodium for Injection Industry Chain Analysis
7.2 Cefuroxime Sodium for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cefuroxime Sodium for Injection Production Mode & Process
7.4 Cefuroxime Sodium for Injection Sales and Marketing
7.4.1 Cefuroxime Sodium for Injection Sales Channels
7.4.2 Cefuroxime Sodium for Injection Distributors
7.5 Cefuroxime Sodium for Injection Customers
8 Cefuroxime Sodium for Injection Market Dynamics
8.1 Cefuroxime Sodium for Injection Industry Trends
8.2 Cefuroxime Sodium for Injection Market Drivers
8.3 Cefuroxime Sodium for Injection Market Challenges
8.4 Cefuroxime Sodium for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’